Collegium Pharmaceutical, Inc
COLL· Nasdaq
COLLCollegium Pharmaceutical, Inc
Filed Aug 12, 2015 · 10-Q · 43 days after period end · 0001104659-15-059155
| Metric | Q2 2015 | Q2 2014 |
|---|---|---|
| Net Income | -$4.67M | -$4.12M |
| EPS Diluted | -$0.45 | -$5.33 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Collegium Pharmaceutical, Inc · CIK 1267565 · Engraved from SEC EDGAR
ended Jun 30, 2015 · filed Aug 12, 2015 · 43 d after period end
